DGAP-News: Post Stab Notice - Bayer AG capital Re-Org


 
DGAP-News: Credit Suisse Securities (Europe) Limited / Key word(s): Miscellaneous Post Stab Notice - Bayer AG capital Re-Org 20.06.2018 / 08:00 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- 20/06/2018 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Bayer Aktiengesellschaft Post-stabilisation Period Announcement Further to the capital increase announcement dated 3rd June 2018, Credit Suisse Securities (Europe) Ltd (contact: Lloyd Adams; telephone: +44 207 888 6341) hereby gives notice that the Stabilisation Manager(s) named below undertook no stabilisation activity (within the meaning of [Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) in relation to the offer of the following securities, as set out below. Issuer: Bayer Aktiengesellschaft Guarantor (if any): N/A Aggregate nominal amount: 74,604,156 shares Description: Ordinary Shares Stabilisation Manager(s): Credit Suisse Securities (Europe) Ltd Offer price: EUR81.00 Stabilisation started: 6th June 2018 Stabilisation last occurred: 20th June 2018 Stabilisation trading venue XETRA No stabilisation trading activity was undertaken This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction. This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com. --------------------------------------------------------------------------- 20.06.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: Credit Suisse Securities (Europe) Limited Taunustor 1 60310 Frankfurt Germany Phone: +49 69 75380 E-mail: [email protected] Internet: www.credit-suisse.com ISIN: DE000BAY0017 WKN: BAY001 Listed: Foreign Exchange(s) SIX End of News DGAP News Service --------------------------------------------------------------------------- 696875 20.06.2018


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 46.085,00 34.943,00 35.015,00 39.586,00 43.545,00 41.400,00 0,00
EBITDA1,2 9.573,00 8.801,00 8.563,00 9.695,00 9.554,00 -2.910,00 0,00
EBITDA-Marge3 20,77 25,19 24,46 24,49 21,94 -7,03 0,00
EBIT1,4 6.241,00 5.738,00 5.903,00 3.454,00 4.189,00 -16.169,00 0,00
EBIT-Marge5 13,54 16,42 16,86 8,73 9,62 -39,06 0,00
Jahresüberschuss1 4.098,00 4.826,00 8.094,00 1.711,00 4.110,00 -10.487,00 0,00
Netto-Marge6 8,89 13,81 23,12 4,32 9,44 -25,33 0,00
Cashflow1,7 6.890,00 9.089,00 8.134,00 7.917,00 8.207,00 4.903,00 0,00
Ergebnis je Aktie8 4,97 5,44 8,41 1,80 4,17 -10,68 3,20
Dividende8 2,50 2,70 2,80 2,80 2,80 2,00 2,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Deloitte

INVESTOR-INFORMATIONEN
©boersengefluester.de
Bayer
WKN Kurs in € Einschätzung Börsenwert in Mio. €
BAY001 50,510 Halten 49.622,24
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
12,95 22,14 0,58 17,90
KBV KCV KUV EV/EBITDA
1,74 10,12 1,20 -30,14
Dividende '19 in € Dividende '20e in € Div.-Rendite '20e
in %
Hauptversammlung
2,80 2,00 3,96 29.04.2022
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
12.05.2021 05.08.2021 09.11.2021 25.02.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-3,68% -1,14% 4,88% -13,61%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Credit Suisse Securities (Europe) Limited  ISIN: DE000BAY0017 können Sie bei DGAP abrufen

Gesundheit , BAY001 , BAYN , XETR:BAYN